Aspen Aerogels (NYSE:ASPN) Hits New 12-Month Low – Time to Sell?

Aspen Aerogels, Inc. (NYSE:ASPN)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $7.17 and last traded at $7.19, with a volume of 2130869 shares traded. The stock had previously closed at $7.61.

Wall Street Analyst Weigh In

ASPN has been the subject of several research reports. Canaccord Genuity Group dropped their price target on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research report on Friday, February 14th. Craig Hallum reduced their target price on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Friday, February 14th. Barclays decreased their price target on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 19th. Roth Mkm dropped their price objective on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Friday, February 14th. Finally, B. Riley decreased their target price on shares of Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating on the stock in a research note on Wednesday, February 19th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Aspen Aerogels presently has a consensus rating of “Moderate Buy” and an average target price of $22.44.

Aspen Aerogels Price Performance

The firm has a market cap of $589.92 million, a price-to-earnings ratio of 44.94 and a beta of 2.14. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The stock’s fifty day moving average price is $11.06 and its 200-day moving average price is $17.40.

Aspen Aerogels (NYSE:ASPN) last posted its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. As a group, equities research analysts forecast that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Bridgewater Advisors Inc. raised its stake in shares of Aspen Aerogels by 37.8% in the 3rd quarter. Bridgewater Advisors Inc. now owns 77,357 shares of the construction company’s stock valued at $2,142,000 after acquiring an additional 21,218 shares during the period. Mesirow Financial Investment Management Inc. acquired a new stake in Aspen Aerogels in the 3rd quarter valued at approximately $252,000. Sigma Planning Corp purchased a new stake in Aspen Aerogels in the third quarter valued at approximately $274,000. Peregrine Asset Advisers Inc. acquired a new position in Aspen Aerogels during the third quarter worth $1,520,000. Finally, Oppenheimer & Co. Inc. boosted its position in shares of Aspen Aerogels by 167.2% during the third quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company’s stock worth $2,839,000 after buying an additional 64,154 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.